Trevi Therapeutics director Michael Thomas Heffernan disposes of USD 595,329 in common shares
TRVI•Director disposes of shares through option exercises and sales
Trevi Therapeutics director Michael Thomas Heffernan cut his direct common stock stake to 6,351 shares on Sep. 15, 2026.
- He disposed of 39,473 shares at USD 15.09 and USD 15.88 through option exercises and sales.
- He exercised options for 39,473 shares at USD 3.04 and USD 3.33.
